Skip to content

EOM Pharmaceutical Holdings, Inc.

Delisted

CIK 822411fmd_10QGK3PZXD6NW2A01FYGM34C6GManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2005 to Jun 30, 2018, 38 periods

Latest annual · FY2017

Millions
Total revenues
0
Operating income
(21)
Net income
(14)
Free cash flow
(17)

Latest quarter · Q2 FY2018

Millions
Total revenues
0
Operating income
(0)
Net income
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2014 to FY2017
n/m
Revenue, 5 yearsFY2012 to FY2017
n/m
Net income, 5 yearsFY2012 to FY2017
n/m

EOM Pharmaceutical Holdings, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2017FY2016ChangeSource
Revenue$0$010-K 2018-03-14 · proof
Operating income-$21.2 million-$24.1 million10-K 2018-03-14 · proof
Net income-$14.3 million-$22.1 million10-K 2018-03-14 · proof
Cash from operating activities-$16.7 million-$19.9 million10-K 2018-03-14 · proof
Free cash flow-$16.7 million-$19.9 million10-K 2018-03-14 · proof
Total assets$7 million$16.9 million-58.5%10-K 2018-03-14 · proof
Total liabilities$2.4 million$10.8 million-78.1%10-K 2018-03-14 · proof
Cash and cash equivalents$6.6 million$11.4 million-42%10-K 2018-03-14 · proof
What was EOM Pharmaceutical Holdings, Inc.'s revenue in fiscal 2017?
EOM Pharmaceutical Holdings, Inc. reported revenue of $0 for fiscal 2017 (the year ended Dec 31, 2017), against $0 the year before. Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
What was EOM Pharmaceutical Holdings, Inc.'s operating income in fiscal 2017?
EOM Pharmaceutical Holdings, Inc. reported operating income of -$21.2 million for fiscal 2017 (the year ended Dec 31, 2017), against -$24.1 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
What was EOM Pharmaceutical Holdings, Inc.'s net income in fiscal 2017?
EOM Pharmaceutical Holdings, Inc. reported net income of -$14.3 million for fiscal 2017 (the year ended Dec 31, 2017), against -$22.1 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
What was EOM Pharmaceutical Holdings, Inc.'s cash from operating activities in fiscal 2017?
EOM Pharmaceutical Holdings, Inc. reported cash from operating activities of -$16.7 million for fiscal 2017 (the year ended Dec 31, 2017), against -$19.9 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
What was EOM Pharmaceutical Holdings, Inc.'s free cash flow in fiscal 2017?
EOM Pharmaceutical Holdings, Inc. reported free cash flow of -$16.7 million for fiscal 2017 (the year ended Dec 31, 2017), against -$19.9 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
What are EOM Pharmaceutical Holdings, Inc.'s total assets?
As of Dec 31, 2017, EOM Pharmaceutical Holdings, Inc. reported total assets of $7 million, against $16.9 million a year earlier (-58.5%). Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
What are EOM Pharmaceutical Holdings, Inc.'s total liabilities?
As of Dec 31, 2017, EOM Pharmaceutical Holdings, Inc. reported total liabilities of $2.4 million, against $10.8 million a year earlier (-78.1%). Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
What are EOM Pharmaceutical Holdings, Inc.'s cash and cash equivalents?
As of Dec 31, 2017, EOM Pharmaceutical Holdings, Inc. reported cash and cash equivalents of $6.6 million, against $11.4 million a year earlier (-42%). Source: the 10-K filed with the SEC on Mar 14, 2018. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:822411&period_type=annual&limit=5"

Information only, not investment advice.